ARCLARCL Organics Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
ARCL Organics Ltd. manufactures and sells resins, additives, hardeners, and specialized one-shot resins in India. The company offers amino and melamine resins, phenolic resins, and formaldehydes. It serves panel, animal feed, rubber, pharma, engineering, textile, paper, foundries, refractories, paints, tire, and various other industries. The company also exports its products to approximately 50 countries. The company was formerly known as AAREM Chemicals (P) Ltd. and changed its name to ARCL Organics Ltd. in April 2011. ARCL Organics Ltd. was founded in 1959 and is based in Kolkata, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on ARCL — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 31/100)
- • Revenue growth: 8.7% YoY
- • Profit growth: -57.9% YoY
- • RSI: 36
- • MACD: bearish
Bull case
- • ROCE: 38.3%
- • Debt/Equity: 0.86
- • Promoter holding: 72.3%
- • Trend strength (ADX): 32
Bear case
- • Revenue growth: 8.7% YoY
- • Profit growth: -57.9% YoY
- • RSI: 36
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Momentum is fading versus the broader market
- • Revenue growth: 8.7% YoY
- • Profit growth: -57.9% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹17.30). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.